AstraZeneca on Thursday appointed company insider Rick Suarez as the head of its U.S. biopharmaceuticals unit to lead the ...

AstraZeneca’s new head of Investor Relations, Joris Silon, succeeds Andy Barnett on 1 March 2026, and will be based in ...

As AstraZeneca floods money into the U.S. market with a wide-ranging investment plan, the company has tapped an in-house executive to lead the surge. | Suarez will return to the U.S. as SVP and ...

If you are wondering whether AstraZeneca shares still offer fair value after a strong run, or if you might be paying too much for the story, this article is designed to help you frame that question ...

On Jan. 4, 2021, a COVID-19 vaccine developed by AstraZeneca and Oxford University was administered for the first time, to an ...

Why AstraZeneca is on investors’ radar today AstraZeneca (LSE:AZN) has been drawing attention after a period of solid share price gains. This is prompting investors to reassess how its current ...

AstraZeneca has named Rick R. Suarez as Senior Vice President, U.S. President and Head of the U.S. Biopharmaceuticals ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

BostonGene, the developer of an AI foundation model for tumor and immune biology, has entered a strategic collaboration with ...

Over 3.4 million people globally are affected by SLE, and it is one of the leading causes of death in young women in the US ...

BostonGene, the developer of the leading AI foundation model for tumor and immune biology, today announced a strategic collaboration with AstraZeneca, a global, science-led biopharmaceutical company ...

AstraZeneca on Thursday appointed company insider Rick Suarez as the head of its U.S. biopharmaceuticals unit to lead the ...